Expression of pRb and PD-L1 as potential predictive biomarkers for oncolytic adenovirus based gene therapy of urothelial carcinoma

被引：0

作者：

Lau, Ryan ^{[1
]}

Chin, Curtis ^{[2
]}

Yu, Weibo ^{[1
]}

Grandi, Paola ^{[3
]}

Shen, Shihpei ^{[3
]}

Lai, Calvin ^{[4
]}

Rao, Jianyu

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Cold Genesys, Santa Ana, CA USA

[4] Cold Genesys, Costa Mesa, CA USA

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

888

引用

页数：2

共 50 条

[31] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
Bocanegra, Ana
Fernandez-Hinojal, Gonzalo
Zuazo-Ibarra, Miren
Arasanz, Hugo
Jesus Garcia-Granda, Maria
Hernandez, Carlos
Ibanez, Maria
Hernandez-Marin, Berta
Martinez-Aguillo, Maite
Jose Lecumberri, Maria
Fernandez de Lascoiti, Angela
Teijeira, Lucia
Morilla, Idoia
Vera, Ruth
Escors, David
Kochan, Grazyna
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
[32] The journey of determining PD-L1 expression in muscle-invasive urothelial carcinoma
Algaba, F.
ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (08): : 553 - 554
[33] Acrodermatitis continua of Hallopeau upon PD-L1 therapy for metastatic urothelial carcinoma
Ickrath, Katrin
Fleissner, Janik
Egenolf, Timo
Schmieder, Astrid
Kerstan, Andreas
EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (03) : 296 - 298
[34] Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
Tomiyama, Eisuke
Fujita, Kazutoshi
Pena, Maria Del Carmen Rodriguez
Taheri, Diana
Banno, Eri
Kato, Taigo
Hatano, Koji
Kawashima, Atsunari
Ujike, Takeshi
Uemura, Motohide
Takao, Tetsuya
Yamaguchi, Seiji
Fushimi, Hiroaki
Yoshimura, Kazuhiro
Uemura, Hirotsugu
Netto, George J.
Nonomura, Norio
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 13
[35] Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions
Burgess, Earle F.
Livasy, Chad
Hartman, Aaron
Robinson, Myra M.
Symanowski, James
Naso, Caroline
Doherty, Shannon
Guerrieri, Renato
Riggs, Stephen
Grigg, Claud M.
Clark, Peter E.
Raghavan, Derek
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (05) : 299.e19 - 299.e25
[36] The expression and clinical significance of PD-L1 in patients with upper tract urothelial carcinoma
Sheng, Xinan
He, Zhisong
Kong, Yan
Chi, Zhihong
Si, Lu
Cui, Chuanliang
Tang, Bixia
Mao, Li Li
Wang, Xuan
Lian, Bin
Yan, Xieqiao
Li, Si Ming
Dai, Jie
Guo, Jun
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[37] PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer
Fan, Yu
Dai, Tao
Zhang, Dahong
Guo, Hongqian
Zhou, Fangjian
Shi, Benkang
Wang, Shaogang
Ji, Zhigang
Wang, Chunxi
Yao, Xudong
Wei, Qiang
Chen, Nanhui
Xing, Jinchun
Yang, Jinjian
Kong, Chuize
Huang, Jian
Ye, Dingwei
Zhou, Liqun
SCIENTIFIC REPORTS, 2024, 14 (01):
[38] Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
Shibata, Yosuke
Kishida, Takeshi
Kouro, Taku
Wei, Feifei
Igarashi, Yuka
Himuro, Hidetomo
Noguchi, Takeaki
Koizumi, Mitsuyuki
Suzuki, Takahisa
Osaka, Kimito
Saigusa, Yusuke
Sasada, Tetsuro
FRONTIERS IN PHARMACOLOGY, 2023, 14
[39] PD-L1 assessment in urothelial carcinoma: a practical approach
Eckstein, Markus
Cimadamore, Alessia
Hartmann, Arndt
Lopez-Beltran, Antonio
Cheng, Liang
Scarpelli, Marina
Montironi, Rodolfo
Gevaert, Thomas
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
[40] PD-L1 testing in urothelial carcinoma: are we there yet?
van Leenders, Geert J. L. H.
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S466 - S468

← 1 2 3 4 5 →